Bioantibody has completed its nearly 100 million CNY first round of financing

Bioantibody has completed its first round of financing totaling nearly 100 million yuan. This financing was led by Fang Fund and followed by New Industry Investment, Guoqian Venture Investment, Bondshine Capital. Phoenix Tree Capital acted as the exclusive financial advisor.

The funds will be used to speed up the in-depth layout of Bioantibody in importing intelligent automated and integrated platforms and personalized customization OEM/ODM platforms for antibodies, IVD products, and related technical service etc..

Bioantibody focuses on the R&D, production and sales of core raw materials for IVD and biopharmaceuticals. Based on the original high-efficiency targeted hybridoma cell fusion technology and the supporting cell stable growth factors and high-throughput screening platform, the company has developed a number of products with performance comparable to or surpassing that of the world’s first-class IVD raw material, and successfully realized commercialization. It has been highly recognized and repeatedly purchased by customers of dozens of well-known IVD listed companies in China.

Bioantibody has since its inception remained true to its original aspiration, pursued continuous innovation and technology-empowered healthcare services.

About Bioantibody

Bioantibody Biotechnology Co., Ltd. (Bioantibody) is a high-tech biotechnology company focused on the R&D and production of antigens, antibodies and downstream detection reagents for diagnosis and therapy. The product pipelines cover cardiovascular and cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, from raw materials to finished products.

Innovation is in our DNA! Bioantibody keeps developing new technologies. Currently, our products have been delivered to more than 60 countries and cities worldwide. Using the ISO 13485 management system, the product quality is greatly trusted by customers. With the mission “Biotech For A Better Life”, we are committed to innovation and providing our best solutions to our customers. We sincerely believe we could make our special contribution to human ecology and health.